2024-11-13 – Press Releases – www.prnewswire.com
– CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum’s disease treatment. – CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum’s disease treatment earlier this year. – CBL-514 Phase 2 study for Dercum’s disease showed…
Mon-Fri 10 am to 7 pm.
Warehouse: (No Walk-In)
Scommerce, 1 Buroh Crescent #03-01
Cogent 1.Logistics Hub S(627545)
Qxpress, 30 Tuas West Rd, level 5, S (638386)
Copyright © 2024 Buy Supplements Online all rights reserved.
All the content on this website, including medical opinion and any other health-related information, are solely to provide information only. Any information/statements on this blog are not intended to diagnose, treat, cure or prevent any disease, and should NOT be a substitute for health and medical advice that can be provided by your own physician/medical doctor. You should always consult a doctor before making any health or diet changes, especially any changes related to a specific diagnosis or condition.
